The Clorox Company’s stock has dropped about 21% in the past month due to ongoing financial struggles, including a 13% decline in organic sales and a significant drop in gross margins. Despite management's optimism about new ERP systems and acquisitions, these factors have not yet shown clear signs of turning the business around. The stock trades at a seemingly attractive forward P/E of 14.5x, but weak profitability and poor momentum justify its lower valuation compared to peers. The analyst downgraded Clorox to a Sell, citing persistent operational challenges and lack of catalysts for recovery.
As of Sep 24, 2026 22:21 WIB, Clorox (CLX) shares are priced at USD 83.45 on Pluang, showing a slight decline of 0.58% in the last day. The stock carries a market cap of $10.15 billion and an enterprise value of $15.53 billion. Despite the recent downgrade and operational challenges noted in the article, Pluang data shows a full 100% buy order activity among its users, highlighting ongoing investor interest.
The Clorox Company announced a quarterly dividend of $1.25 per share, payable on November 13, 2026, to shareholders recorded by October 28, 2026. This continues Clorox's tradition of rewarding shareholders with regular dividends and annual increases....
Clorox has been downgraded from hold to sell due to worsening fundamentals, including a 13% decline in organic sales in Q4 despite acquiring GOJO. The company's long-term debt has surged to nearly $4 billion, raising concerns in a high interest rate ...
Clorox and Kimberly-Clark both offer dividend yields above 5%, but Kimberly-Clark's dividend is safer. Clorox's payout is nearly equal to its operating cash flow and management admits the dividend is elevated and may not be sustainable. Its balance s...
